Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Researchers Testing Whether Biomarkers In Saliva Could Predict COVID-19 Disease Severity In Children

    Fox News (10/8, Rivas) reports researchers are collecting saliva samples from 400 pediatric patients with COVID-19 to determine whether “certain biomarkers in saliva may help predict COVID-19 severity in children, according to the American Academy of Pedi...
    Full Article
  • Flu Vaccines Based On mRNA Technology May Emerge In Coming Years

    The New York Times (10/9, Zimmer) reported that “a new generation of highly effective flu vaccines may emerge in the next few years, based on the same mRNA technology that has protected hundreds of millions of people against Covid-19.” Though conventional...
    Full Article
  • New Ebola Case Confirmed In Democratic Republic Of Congo

    Reuters (10/8, Mahamba) reported, “A case of Ebola has been confirmed in eastern Democratic Republic of Congo, the health minister said on Friday, five months after the end of the most recent outbreak there.” It is unclear “if the case was related to the...
    Full Article
  • Investigational Antibody Therapy AZD7442 Effective In Reducing Severe Illness, Death In Patients With COVID-19, Drugmaker Says

    The Hill (10/11, Choi) reports AstraZeneca issued data Monday showing its investigational “COVID-19 treatment has been found to be effective in late-stage trials at preventing severe illness or death.” When compared to placebo, antibody treatment AZD7442...
    Full Article
  • Social Distancing, Mask Mandates Prevents Cases Of Flu, RSV Among Children, Study Suggests

    HealthDay (10/8, Preidt) reported research suggests that “social distancing and mask mandates during the pandemic nearly eliminated cases of the flu and respiratory syncytial virus (RSV) among children.” Researchers found “no cases of RSV at” Akron Childr...
    Full Article
  • COVID-19 Booster Shots Providing Needed Protection To Vulnerable, Raising Skepticism Among Some Vaccine Hesitant Individuals

    The New York Times (10/11, A1, Hoffman) says even as coronavirus booster shots “are providing added protection for vulnerable populations, they are raising further doubts among people” who see the need for a booster as evidence the vaccines don’t work. So...
    Full Article
  • Federal Government Takes Control Of Distribution Of COVID-19 Therapy Sotrovimab

    Reuters (10/8, Mishra) reports the FDA on Friday said the federal government would take over distribution of GlaxoSmithKline and Vir Biotechnology’s antibody therapy for COVID-19, sotrovimab. It remains unclear whether the government has signed an agreeme...
    Full Article
  • WHO’s SAGE Recommends COVID-19 Vaccine Boosters For Immunocompromised People

    Reuters (10/11, Nebehay, Farge) reports the World Health Organization’s Strategic Advisory Group of Experts (SAGE) “on Monday recommended that immunocompromised people be given an additional dose of COVID-19 vaccine, due to their higher risk of breakthrou...
    Full Article
  • Seniors Disproportionately Affected By Antibiotic-Resistant Infections, Study Finds

    STAT (10/7, Silverman) reports, “Older Americans were disproportionately affected by several different types of infection for which antibiotics were largely ineffective, resulting in nearly 12,000 deaths and costing the U.S. health care system almost $1.9...
    Full Article
  • Study Examines Cerebrospinal Fluid Diffusion Of Bictegravir/Emtricitabine/Tenofovir In HIV-Related Central Nervous System Impairment

    Infectious Disease Advisor (10/7, Gupta) reports, “Among patients younger than 51 years of age with HIV-related central nervous system impairment (HCI), first-line treatment with an antiretroviral (ART) regimen of bictegravir, emtricitabine, and tenofovir...
    Full Article
  • Sanofi Announces Positive Results From Study Mixing Influenza Vaccine With Moderna COVID-19 Booster

    Reuters (10/7, Kar-Gupta) reports “French healthcare company Sanofi said on Wednesday that it had found positive results from the first study into a high-dose influenza vaccine with a COVID-19 mRNA booster.” The company “said the interim results from the...
    Full Article
  • CDC Data Show Number Of COVID-19 Vaccine Booster Shots Being Administered Outpaces First Or Second Doses

    NBC News (10/7, Ramos) reports an analysis of CDC “data shows that the number of people receiving booster shots is outpacing those getting their first or second doses of the initial vaccination, and is contributing to a modest increase in Covid vaccinatio...
    Full Article
  • Africa Optimistic New Vaccine Will “Dramatically Change” Fight Against Malaria

    The AP (10/7, Asadu) reports, “African health officials are optimistic that the world’s first malaria vaccine endorsed by the World Health Organization will ‘dramatically change’ the way the continent of 1.3 billion people fights the disease.” The news of...
    Full Article
  • Study Finds PrEP Awareness, Referrals Low Among Hispanic, Latino Populations

    Healio (10/7, Downey) reports, “Only around a quarter of Hispanic/Latino people receiving a CDC-funded HIV test were aware of PrEP, and an even smaller proportion of those eligible for the HIV prevention medication were referred to a PrEP provider, a stud...
    Full Article
  • Health Experts Concerned About Possibility Of Severe Flu Season As Many Americans Say They May Not Get Vaccine

    The New York Times (10/7, Hoffman) reports, “Lockdowns helped keep last year’s flu season historically mild in both the United States and around the world, but U.S. officials fear a more serious season this fall and winter, with unmasked people out and ab...
    Full Article
  • COVID-19 Pandemic Causes Decline In Routine Vaccination Rates For Children, Study Indicates

    MedPage Today (10/7, Hamza) reports, “With pandemic disruptions aplenty, fewer infants were left up to date (UTD) with their routine vaccinations through the fall of last year, and weekly vaccination rates remained depressed for several age groups as well...
    Full Article
  • Pfizer, BioNTech Ask FDA To Authorize Coronavirus Vaccine For Emergency Use For Children 5 To 11 Years Old

    The New York Times (10/7, A1, LaFraniere, Weiland) reports, “Pfizer and BioNTech asked federal regulators on Thursday to authorize emergency use of their coronavirus vaccine for children ages 5 to 11.” NBC News (10/7, Burke, Chuck) reports, “An FDA adviso...
    Full Article
  • White House Adviser Says Pfizer Vaccine For Children May Be Ready In November

    Reuters (10/7, Chiacu) reports, “Pfizer Inc’s new vaccine for children aged five to 11 could be ready as early as November pending approval from federal regulatory health agencies, White House COVID-19 response coordinator Jeffrey Zients said on Thursday....
    Full Article
  • An Environmental Call to Action for Healthcare

    Abstract Not Available
    Full Article
  • Anti-S Antibody: A Rare Cause of Fetal Hydrops in a Previously Sensitized Mother

    Abstract Not Available
    Full Article
  • «
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id